HPGC Renmintongtai Pharmaceutical Corporation

SHSE:600829 Stock Report

Market Cap: CN¥4.1b

HPGC Renmintongtai Pharmaceutical Balance Sheet Health

Financial Health criteria checks 4/6

HPGC Renmintongtai Pharmaceutical has a total shareholder equity of CN¥2.9B and total debt of CN¥894.3M, which brings its debt-to-equity ratio to 31.1%. Its total assets and total liabilities are CN¥7.0B and CN¥4.2B respectively. HPGC Renmintongtai Pharmaceutical's EBIT is CN¥356.9M making its interest coverage ratio 90.6. It has cash and short-term investments of CN¥795.9M.

Key information

31.1%

Debt to equity ratio

CN¥894.28m

Debt

Interest coverage ratio90.6x
CashCN¥795.87m
EquityCN¥2.87b
Total liabilitiesCN¥4.16b
Total assetsCN¥7.03b

Recent financial health updates

Recent updates

Is HPGC Renmintongtai Pharmaceutical (SHSE:600829) A Risky Investment?

Oct 01
Is HPGC Renmintongtai Pharmaceutical (SHSE:600829) A Risky Investment?

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Might Be Having Difficulty Using Its Capital Effectively

Sep 05
HPGC Renmintongtai Pharmaceutical (SHSE:600829) Might Be Having Difficulty Using Its Capital Effectively

Financial Position Analysis

Short Term Liabilities: 600829's short term assets (CN¥6.5B) exceed its short term liabilities (CN¥4.0B).

Long Term Liabilities: 600829's short term assets (CN¥6.5B) exceed its long term liabilities (CN¥145.1M).


Debt to Equity History and Analysis

Debt Level: 600829's net debt to equity ratio (3.4%) is considered satisfactory.

Reducing Debt: 600829's debt to equity ratio has increased from 23.7% to 31.1% over the past 5 years.

Debt Coverage: 600829's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 600829's interest payments on its debt are well covered by EBIT (90.6x coverage).


Balance Sheet


Discover healthy companies